{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:09:24Z","timestamp":1793848164844,"version":"4.6.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanisms of neuroimmune and mitochondrial dysfunction have been repeatedly implicated in autism spectrum disorder (ASD). To examine these mechanisms in ASD individuals, we measured the in vivo expression of the 18\u2009kDa translocator protein (TSPO), an activated glial marker expressed on mitochondrial membranes. Participants underwent scanning on a simultaneous magnetic resonance\u2013positron emission tomography (MR\u2013PET) scanner with the second-generation TSPO radiotracer [<jats:sup>11<\/jats:sup>C]PBR28. By comparing TSPO in 15 young adult males with ASD with 18 age- and sex-matched controls, we showed that individuals with ASD exhibited lower regional TSPO expression in several brain regions, including the bilateral insular cortex, bilateral precuneus\/posterior cingulate cortex, and bilateral temporal, angular, and supramarginal gyri, which have previously been implicated in autism in functional MR imaging studies. No brain region exhibited higher regional TSPO expression in the ASD group compared with the control group. A subset of participants underwent a second MR\u2013PET scan after a median interscan interval of 3.6 months, and we determined that TSPO expression over this period of time was stable and replicable. Furthermore, voxelwise analysis confirmed lower regional TSPO expression in ASD at this later time point. Lower TSPO expression in ASD could reflect abnormalities in neuroimmune processes or mitochondrial dysfunction.<\/jats:p>","DOI":"10.1038\/s41380-020-0682-z","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T11:03:30Z","timestamp":1582110210000},"page":"1659-1669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["[11C]PBR28 MR\u2013PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0271-6304","authenticated-orcid":false,"given":"N. R.","family":"Z\u00fcrcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Loggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Mullett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-335X","authenticated-orcid":false,"given":"C.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bhanot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Richey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. G.","family":"Hightower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. I.","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. B.","family":"Chonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Izquierdo-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Y.","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Catana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-3106","authenticated-orcid":false,"given":"N.","family":"Hadjikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"McDougle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"AP Association","year":"2013","unstructured":"AP Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: Author; 2013.","edition":"5th ed."},{"key":"682_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","volume":"67","author":"J Baio","year":"2018","unstructured":"Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et al. Prevalence of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67:1\u201323.","journal-title":"MMWR Surveill Summ"},{"key":"682_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature20612","volume":"540","author":"NN Parikshak","year":"2016","unstructured":"Parikshak NN, Swarup V, Belgard TG, Irimia M, Ramaswami G, Gandal MJ, et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature. 2016;540:423\u20137.","journal-title":"Nature"},{"key":"682_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2013.01.006","volume":"54","author":"G Tang","year":"2013","unstructured":"Tang G, Gutierrez Rios P, Kuo SH, Akman HO, Rosoklija G, Tanji K, et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis. 2013;54:349\u201361.","journal-title":"Neurobiol Dis"},{"key":"682_CR5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10110","volume":"474","author":"I Voineagu","year":"2011","unstructured":"Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380\u20134.","journal-title":"Nature"},{"key":"682_CR6","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6748","volume":"5","author":"S Gupta","year":"2014","unstructured":"Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J, et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun. 2014;5:5748.","journal-title":"Nat Commun"},{"key":"682_CR7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10803-010-1006-y","volume":"40","author":"HO Atladottir","year":"2010","unstructured":"Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40:1423\u201330.","journal-title":"J Autism Dev Disord"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/oxfordjournals.aje.a112726","volume":"109","author":"EY Deykin","year":"1979","unstructured":"Deykin EY, MacMahon B. Viral exposure and autism. Am J Epidemiol. 1979;109:628\u201338.","journal-title":"Am J Epidemiol"},{"key":"682_CR9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/00207450290026076","volume":"112","author":"DS Wilkerson","year":"2002","unstructured":"Wilkerson DS, Volpe AG, Dean RS, Titus JB. Perinatal complications as predictors of infantile autism. Int J Neurosci. 2002;112:1085\u201398.","journal-title":"Int J Neurosci"},{"key":"682_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jamapsychiatry.2019.0029","volume":"76","author":"BJS Al-Haddad","year":"2019","unstructured":"Al-Haddad BJS, Jacobsson B, Chabra S, Modzelewska D, Olson EM, Bernier R, et al. Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatry. 2019;76:594\u2013602.","journal-title":"JAMA Psychiatry"},{"key":"682_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/mp.2012.197","volume":"19","author":"AS Brown","year":"2014","unstructured":"Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry. 2014;19:259\u201364.","journal-title":"Mol Psychiatry"},{"key":"682_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/mp.2016.77","volume":"22","author":"KL Jones","year":"2017","unstructured":"Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, et al. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry. 2017;22:273\u20139.","journal-title":"Mol Psychiatry"},{"key":"682_CR13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/088307389901400608","volume":"14","author":"AM Comi","year":"1999","unstructured":"Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14:388\u201394.","journal-title":"J Child Neurol"},{"key":"682_CR14","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1542\/peds.112.5.e420","volume":"112","author":"TL Sweeten","year":"2003","unstructured":"Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112:e420.","journal-title":"Pediatrics"},{"key":"682_CR15","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/art.39320","volume":"67","author":"E Vinet","year":"2015","unstructured":"Vinet E, Pineau CA, Clarke AE, Scott S, Fombonne E, Joseph L, et al. Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort. Arthritis Rheumatol. 2015;67:3201\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"682_CR16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/mp.2014.59","volume":"20","author":"A Masi","year":"2015","unstructured":"Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2015;20:440\u20136.","journal-title":"Mol Psychiatry"},{"key":"682_CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.biopsych.2015.08.036","volume":"81","author":"M Careaga","year":"2015","unstructured":"Careaga M, Rogers S, Hansen RL, Amaral DG, Van de Water J, Ashwood P. Immune endophenotypes in children with autism spectrum disorder. Biol Psychiatry. 2015;81:434\u201341.","journal-title":"Biol Psychiatry"},{"key":"682_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-012-2796-8","volume":"225","author":"M Asadabadi","year":"2013","unstructured":"Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, et al. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Psychopharmacology. 2013;225:51\u20139.","journal-title":"Psychopharmacology"},{"key":"682_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17:290\u2013314.","journal-title":"Mol Psychiatry"},{"key":"682_CR20","doi-asserted-by":"publisher","unstructured":"Siddiqui MF, Elwell C, Johnson MH. Mitochondrial dysfunction in autism spectrum disorders. Autism Open Access. 2016;6:190. https:\/\/doi.org\/10.4172\/2165-7890.1000190.","DOI":"10.4172\/2165-7890.1000190"},{"key":"682_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1471-4159.2011.07189.x","volume":"117","author":"A Chauhan","year":"2011","unstructured":"Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, et al. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem. 2011;117:209\u201320.","journal-title":"J Neurochem"},{"key":"682_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mp.2008.63","volume":"15","author":"L Palmieri","year":"2010","unstructured":"Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate\/glutamate carrier AGC1. Mol Psychiatry. 2010;15:38\u201352.","journal-title":"Mol Psychiatry"},{"key":"682_CR23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9:971\u201388.","journal-title":"Nat Rev Drug Discov"},{"key":"682_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","volume":"70","author":"K Suzuki","year":"2013","unstructured":"Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, et al. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry. 2013;70:49\u201358.","journal-title":"JAMA Psychiatry"},{"key":"682_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/2040-2392-3-12","volume":"3","author":"A Anitha","year":"2012","unstructured":"Anitha A, Nakamura K, Thanseem I, Yamada K, Iwayama Y, Toyota T, et al. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol Autism. 2012;3:12.","journal-title":"Mol Autism"},{"key":"682_CR26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2015.02.002","volume":"52","author":"NR Zurcher","year":"2015","unstructured":"Zurcher NR, Bhanot A, McDougle CJ, Hooker JM. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities. Neurosci Biobehav Rev. 2015;52:56\u201373.","journal-title":"Neurosci Biobehav Rev"},{"key":"682_CR27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jcpp.12720","volume":"58","author":"B Chakrabarti","year":"2017","unstructured":"Chakrabarti B. Commentary: critical considerations for studying low-functioning autism. J Child Psychol Psychiatry. 2017;58:436\u20138.","journal-title":"J Child Psychol Psychiatry"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jcpp.12687","volume":"58","author":"A Jack","year":"2017","unstructured":"Jack A, K AP. Annual research review: understudied populations within the autism spectrum\u2014current trends and future directions in neuroimaging research. J Child Psychol Psychiatry. 2017;58:411\u201335.","journal-title":"J Child Psychol Psychiatry"},{"key":"682_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10717","volume":"7","author":"DM Werling","year":"2016","unstructured":"Werling DM, Parikshak NN, Geschwind DH. Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders. Nat Commun. 2016;7:10717.","journal-title":"Nat Commun"},{"key":"682_CR30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2967\/jnumed.111.091694","volume":"53","author":"J Hirvonen","year":"2012","unstructured":"Hirvonen J, Kreisl WC, Fujita M, Dustin I, Khan O, Appel S, et al. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med. 2012;53:234\u201340.","journal-title":"J Nucl Med"},{"key":"682_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32:1\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"key":"682_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2967\/jnumed.116.178335","volume":"59","author":"DS Albrecht","year":"2017","unstructured":"Albrecht DS, Normandin MD, Shcherbinin S, Wooten DW, Schwarz AJ, Zurcher NR, et al. Pseudo-reference regions for glial imaging with 11C-PBR28: investigation in two clinical cohorts. J Nucl Med. 2017;59:107\u201314.","journal-title":"J Nucl Med"},{"key":"682_CR33","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1212\/WNL.0000000000003427","volume":"87","author":"MJ Alshikho","year":"2016","unstructured":"Alshikho MJ, Zurcher NR, Loggia ML, Cernasov P, Chonde DB, Izquierdo Garcia D, et al. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology. 2016;87:2554\u201361.","journal-title":"Neurology"},{"key":"682_CR34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ana.25251","volume":"83","author":"MJ Alshikho","year":"2018","unstructured":"Alshikho MJ, Zurcher NR, Loggia ML, Cernasov P, Reynolds B, Pijanowski O, et al. Integrated magnetic resonance imaging and [(11) C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis. Ann Neurol. 2018;83:1186\u201397.","journal-title":"Ann Neurol"},{"key":"682_CR35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/brain\/awu377","volume":"138","author":"ML Loggia","year":"2015","unstructured":"Loggia ML, Chonde DB, Akeju O, Arabasz G, Catana C, Edwards RR, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138:604\u201315.","journal-title":"Brain"},{"key":"682_CR36","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1021\/acschemneuro.8b00072","volume":"9","author":"C Lois","year":"2018","unstructured":"Lois C, Gonzalez I, Izquierdo-Garcia D, Zurcher NR, Wilkens P, Loggia ML, et al. Neuroinflammation in Huntington\u2019s disease: new insights with (11)C-PBR28 PET\/MRI. ACS Chem Neurosci. 2018;9:2563\u201371.","journal-title":"ACS Chem Neurosci"},{"key":"682_CR37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mus.26385","volume":"59","author":"S Paganoni","year":"2018","unstructured":"Paganoni S, Alshikho MJ, Luppino S, Chan J, Pothier L, Schoenfeld D, et al. A pilot trial of RNS60 in amyotrophic lateral sclerosis. Muscle Nerve. 2018;59:303\u20138.","journal-title":"Muscle Nerve"},{"key":"682_CR38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nicl.2017.10.024","volume":"17","author":"S Paganoni","year":"2018","unstructured":"Paganoni S, Alshikho MJ, Zurcher NR, Cernasov P, Babu S, Loggia ML, et al. Imaging of glia activation in people with primary lateral sclerosis. Neuroimage Clin. 2018;17:347\u201353.","journal-title":"Neuroimage Clin"},{"key":"682_CR39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nicl.2018.08.007","volume":"20","author":"EM Ratai","year":"2018","unstructured":"Ratai EM, Alshikho MJ, Zurcher NR, Loggia ML, Cebulla CL, Cernasov P, et al. Integrated imaging of [(11)C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy (1)H-MRS in amyotrophic lateral sclerosis. Neuroimage Clin. 2018;20:357\u201364.","journal-title":"Neuroimage Clin"},{"key":"682_CR40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nicl.2015.01.009","volume":"7","author":"NR Zurcher","year":"2015","unstructured":"Zurcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin. 2015;7:409\u201314.","journal-title":"Neuroimage Clin"},{"key":"682_CR41","volume-title":"Diagnostic and statistical manual of mental disorders","author":"AP Association","year":"2000","unstructured":"AP Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author; 2000.","edition":"4th ed."},{"key":"682_CR42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659\u201385.","journal-title":"J Autism Dev Disord"},{"key":"682_CR43","volume-title":"Autism diagnostic interview-revised","author":"M Rutter","year":"2003","unstructured":"Rutter M, Le Couteur A, Lord C. Autism diagnostic interview-revised. Los Angeles, CA: Western Psychological Services; 2003."},{"key":"682_CR44","volume-title":"Autism diagnostic observation schedule: ADOS-2","author":"C Lord","year":"2012","unstructured":"Lord C, Rutter M, DiLavore PC, Risi S, Gotham K, Bishop S. Autism diagnostic observation schedule: ADOS-2. 2nd ed. Los Angeles, CA: Western Psychological Services; 2012.","edition":"2nd ed."},{"key":"682_CR45","volume-title":"Autism diagnostic observation schedule (ADOS)","author":"C Lord","year":"1999","unstructured":"Lord C, Rutter M, DiLavore P, Risi S. Autism diagnostic observation schedule (ADOS). Los Angeles, CA: Western Psychological Services; 1999."},{"key":"682_CR46","volume-title":"Stanford\u2013Binet intelligence scales","author":"G Roid","year":"2003","unstructured":"Roid G. Stanford\u2013Binet intelligence scales. 5th ed. Itasca, IL: Riverside Publishing; 2003","edition":"5th ed."},{"key":"682_CR47","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1007\/s10803-019-04010-3","volume":"49","author":"CJ Smith","year":"2019","unstructured":"Smith CJ, Bhanot A, Norman E, Mullett JE, Bilbo SD, McDougle CJ, et al. A protocol for sedation free MRI and PET imaging in adults with autism spectrum disorder. J Autism Dev Disord. 2019;49:3036\u201344.","journal-title":"J Autism Dev Disord"},{"key":"682_CR48","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s00330-012-2415-4","volume":"22","author":"A Kolb","year":"2012","unstructured":"Kolb A, Wehrl HF, Hofmann M, Judenhofer MS, Eriksson L, Ladebeck R, et al. Technical performance evaluation of a human brain PET\/MRI system. Eur Radio. 2012;22:1776\u201388.","journal-title":"Eur Radio"},{"key":"682_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroimage.2015.11.054","volume":"127","author":"MD Tisdall","year":"2016","unstructured":"Tisdall MD, Reuter M, Qureshi A, Buckner RL, Fischl B, van der Kouwe AJW. Prospective motion correction with volumetric navigators (vNavs) reduces the bias and variance in brain morphometry induced by subject motion. Neuroimage. 2016;127:11\u201322.","journal-title":"Neuroimage"},{"key":"682_CR50","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2967\/jnumed.113.136341","volume":"55","author":"D Izquierdo-Garcia","year":"2014","unstructured":"Izquierdo-Garcia D, Hansen AE, Forster S, Benoit D, Schachoff S, Furst S, et al. An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET\/MR brain imaging. J Nucl Med. 2014;55:1825\u201330.","journal-title":"J Nucl Med"},{"key":"682_CR51","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neuroimage.2016.12.010","volume":"147","author":"CN Ladefoged","year":"2017","unstructured":"Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, et al. A multi-centre evaluation of eleven clinically feasible brain PET\/MRI attenuation correction techniques using a large cohort of patients. Neuroimage. 2017;147:346\u201359.","journal-title":"Neuroimage"},{"key":"682_CR52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17:825\u201341.","journal-title":"Neuroimage"},{"key":"682_CR53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307\u201310.","journal-title":"Lancet"},{"key":"682_CR54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","volume":"92","author":"AM Winkler","year":"2014","unstructured":"Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92:381\u201397.","journal-title":"Neuroimage"},{"key":"682_CR55","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.neuroimage.2003.12.023","volume":"21","author":"MW Woolrich","year":"2004","unstructured":"Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage. 2004;21:1732\u201347.","journal-title":"Neuroimage"},{"key":"682_CR56","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10803-014-2080-3","volume":"44","author":"V Hus","year":"2014","unstructured":"Hus V, Lord C. The autism diagnostic observation schedule, module 4: revised algorithm and standardized severity scores. J Autism Dev Disord. 2014;44:1996\u20132012.","journal-title":"J Autism Dev Disord"},{"key":"682_CR57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/mp.2017.232","volume":"23","author":"T Notter","year":"2018","unstructured":"Notter T, Coughlin JM, Sawa A, Meyer U. Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry. Mol Psychiatry. 2018;23:36\u201347.","journal-title":"Mol Psychiatry"},{"key":"682_CR58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2016.04.011","volume":"44","author":"WC Kreisl","year":"2016","unstructured":"Kreisl WC, Lyoo CH, Liow JS, Wei M, Snow J, Page E. et al. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer\u02bcs disease. Neurobiol Aging. 2016;44:53\u201361.","journal-title":"Neurobiol Aging"},{"key":"682_CR59","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, Herard AS, Petit F, Delahaye M, Van Camp N, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. 2012;32:10809\u201318.","journal-title":"J Neurosci"},{"key":"682_CR60","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/jcbfm.2014.55","volume":"34","author":"G Rizzo","year":"2014","unstructured":"Rizzo G, Veronese M, Tonietto M, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A. Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data. J Cereb Blood Flow Metab. 2014;34:1060\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"682_CR61","doi-asserted-by":"publisher","unstructured":"Bonsack F, Sukumari-Ramesh S. TSPO: an evolutionarily conserved protein with elusive functions. Int J Mol Sci. 2018;19:1694\u2013706. https:\/\/doi.org\/10.3390\/ijms19061694.","DOI":"10.3390\/ijms19061694"},{"key":"682_CR62","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/mp.2016.103","volume":"22","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Cho MH, Shim WH, Kim JK, Jeon EY, Kim DH, et al. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol Psychiatry. 2016;22:1576\u201384.","journal-title":"Mol Psychiatry"},{"key":"682_CR63","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2016.247","volume":"22","author":"K Collste","year":"2017","unstructured":"Collste K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, et al. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28. Mol Psychiatry. 2017;22:850\u20136.","journal-title":"Mol Psychiatry"},{"key":"682_CR64","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.40","volume":"6","author":"JM Coughlin","year":"2016","unstructured":"Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016;6:e777.","journal-title":"Transl Psychiatry"},{"key":"682_CR65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.2016.16020171","volume":"174","author":"S Hafizi","year":"2017","unstructured":"Hafizi S, Tseng HH, Rao N, Selvanathan T, Kenk M, Bazinet RP, et al. Imaging microglial activation in untreated first-episode psychosis: a PET study with [(18)F]FEPPA. Am J Psychiatry. 2017;174:118\u201324.","journal-title":"Am J Psychiatry"},{"key":"682_CR66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/schbul\/sbu157","volume":"41","author":"M Kenk","year":"2015","unstructured":"Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G, et al. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull. 2015;41:85\u201393.","journal-title":"Schizophr Bull"},{"key":"682_CR67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2016","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR, et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am J Psychiatry. 2016;173:44\u201352.","journal-title":"Am J Psychiatry"},{"key":"682_CR68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/mp.2016.248","volume":"23","author":"T Notter","year":"2018","unstructured":"Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, et al. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry. 2018;23:323\u201334.","journal-title":"Mol Psychiatry"},{"key":"682_CR69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/bpa.12196","volume":"24","author":"GJ Liu","year":"2014","unstructured":"Liu GJ, Middleton RJ, Hatty CR, Kam WW, Chan R, Pham T, et al. The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 2014;24:631\u201353.","journal-title":"Brain Pathol"},{"key":"682_CR70","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.neuroimage.2009.11.056","volume":"49","author":"WC Kreisl","year":"2010","unstructured":"Kreisl WC, Fujita M, Fujimura Y, Kimura N, Jenko KJ, Kannan P, et al. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage. 2010;49:2924\u201332.","journal-title":"Neuroimage"},{"key":"682_CR71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40336-015-0140-0","volume":"3","author":"TF van der Doef","year":"2015","unstructured":"van der Doef TF, Doorduin J, van Berckel BNM, Cervenka S. Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein. Clin Transl Imaging. 2015;3:449\u201360.","journal-title":"Clin Transl Imaging"},{"key":"682_CR72","doi-asserted-by":"crossref","first-page":"e110356","DOI":"10.1371\/journal.pone.0110356","volume":"9","author":"JT Morgan","year":"2014","unstructured":"Morgan JT, Barger N, Amaral DG, Schumann CM. Stereological study of amygdala glial populations in adolescents and adults with autism spectrum disorder. PLoS ONE. 2014;9:e110356.","journal-title":"PLoS ONE"},{"key":"682_CR73","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","volume":"68","author":"JT Morgan","year":"2010","unstructured":"Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, Buckwalter J, et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry. 2010;68:368\u201376.","journal-title":"Biol Psychiatry"},{"key":"682_CR74","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s10803-012-1513-0","volume":"42","author":"NA Tetreault","year":"2012","unstructured":"Tetreault NA, Hakeem AY, Jiang S, Williams BA, Allman E, Wold BJ, et al. Microglia in the cerebral cortex in autism. J Autism Dev Disord. 2012;42:2569\u201384.","journal-title":"J Autism Dev Disord"},{"key":"682_CR75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67\u201381.","journal-title":"Ann Neurol"},{"key":"682_CR76","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaneurol.2015.0941","volume":"72","author":"LD Gershen","year":"2015","unstructured":"Gershen LD, Zanotti-Fregonara P, Dustin IH, Liow JS, Hirvonen J, Kreisl WC, et al. Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein. JAMA Neurol. 2015;72:882\u20138.","journal-title":"JAMA Neurol"},{"key":"682_CR77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Forsberg A, Sandstrom A, Bergan C, Kadetoff D, Protsenko E, et al. Brain glial activation in fibromyalgia\u2014a multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72\u201383.","journal-title":"Brain Behav Immun"},{"key":"682_CR78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2967\/jnumed.114.146027","volume":"56","author":"CH Lyoo","year":"2015","unstructured":"Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, et al. Cerebellum can serve as a pseudo-reference region in Alzheimer Disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med. 2015;56:701\u20136.","journal-title":"J Nucl Med"},{"key":"682_CR79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euroneuro.2007.04.005","volume":"18","author":"L Danovich","year":"2008","unstructured":"Danovich L, Veenman L, Leschiner S, Lahav M, Shuster V, Weizman A, et al. The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production. Eur Neuropsychopharmacol. 2008;18:24\u201333.","journal-title":"Eur Neuropsychopharmacol"},{"key":"682_CR80","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-018-0401-9","volume":"8","author":"EM Richards","year":"2018","unstructured":"Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, et al. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res. 2018;8:57.","journal-title":"EJNMMI Res"},{"key":"682_CR81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrn.2017.61","volume":"18","author":"MM McCarthy","year":"2017","unstructured":"McCarthy MM, Nugent BM, Lenz KM. Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain. Nat Rev Neurosci. 2017;18:471\u201384.","journal-title":"Nat Rev Neurosci"},{"key":"682_CR82","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/toxsci\/kfz096","volume":"170","author":"BA Hobson","year":"2019","unstructured":"Hobson BA, Rowland DJ, Siso S, Guignet MA, Harmany ZT, Bandara SB, et al. TSPO PET using [18F]PBR111 reveals persistent neuroinflammation following acute diisopropylfluorophosphate intoxication in the rat. Toxicol Sci. 2019;170:330\u201344.","journal-title":"Toxicol Sci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0682-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:32Z","timestamp":1684616492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0682-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1038\/s41380-020-0682-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,19]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the past year, Dr. Hooker has consulted for Psy Therapeutics, Amathus Therapeutics, Evelo Biosciences, Rodin Therapeutics, and the Alzheimer\u2019s Drug Discovery Foundation. He is a co-founder and equity holder in Eikonizo Therapeutics and has received honoraria for speaking or advisory service at nonprofit academic institutions. Dr. Hadjikhani is a co-founder of Neurochlore. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}